Evidence map›Paper›PMID 36014390›Full record

ReviewMolecules (Basel, Switzerland)2022

Recent Overview of Resveratrol's Beneficial Effects and Its Nano-Delivery Systems.

Raghvendra A Bohara, Nazish Tabassum, Mohan P Singh, Giuseppe Gigli, Andrea Ragusa, Stefano Leporatti

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. The Effects of Resveratrol on Menopausal Cardio-metabolic Changes: A Systematic Review.Cardiovascular & hematological disorders drug targets · 2026
    Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Raghvendra A BoharaCÚRAM, SFI Research Centre For Medical Devices, National University of Ireland Galway, H91 W2TY Galway, Ireland.ORCID 0000-0001-6654-9627
Nazish TabassumCentre of Biotechnology, University of Allahabad, Prayagraj 211002, India.ORCID 0000-0002-8214-4096
Mohan P SinghCentre of Biotechnology, University of Allahabad, Prayagraj 211002, India.ORCID 0000-0002-6236-856X
Giuseppe GigliCNR NANOTEC-Istituto di Nanotecnologia, 73100 Lecce, Italy.
Andrea RagusaCNR NANOTEC-Istituto di Nanotecnologia, 73100 Lecce, Italy.ORCID 0000-0002-2198-6185
Stefano LeporattiCNR NANOTEC-Istituto di Nanotecnologia, 73100 Lecce, Italy.ORCID 0000-0001-5912-7565

Funding

Tecnopolo di Nanotecnologia e Fotonica per la medicina di precisione (TECNO-MED)-FISR/MIUR-CNR: delibera CIPE no. 3449 del 7-08-2017 CUP: B83B17000010001.Tecnopolo per la medicina di precisione (TecnoMed Puglia)-Regione Puglia: DGR no. 2117 del 21/11/2018 CUP: B84I18000540002
6 · The paper itself

Abstract

Natural polyphenols have a wide variety of biological activities and are taken into account as healthcare materials. Resveratrol is one such natural polyphenol, belonging to a group known as stilbenoids (STBs). Resveratrol (3,5,4'-trihydroxy-

Indexed as

PolyphenolsStilbenesAntioxidantsNanoparticle Drug Delivery SystemResveratrolAntioxidantsNanoparticle Drug Delivery SystemPolyphenolsResveratrolStilbenesdrug deliverynanocarriersnanomedicinepolyphenolsresveratrol

Identifiers

PMID36014390
PMCPMC9414442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.